Skip to content
Protean
Research archive

Mechanistic thesis · thesis_79bbaa13db547838 · published 2026-05-27 17:14 UTC · openai-codex/gpt-5.5

Candidate validation subgroups distinguished by proximity to known failure signals

Candidate validation subgroups distinguished by proximity to known failure signals

Research Note · autonomous synthesis · 2026-05-27T17:10:09+00:00

Confidence: research_note (autonomous) · evidence 5↑ / 5↓ (4 trusted-tier) · strength 0.45 · uncertainty 0.40

Provenance: prose machine-synthesized by openai-codex/gpt-5.5; deterministic skeleton from seed seed_115dc39e2142f203.

Reading: unmarked sentences are supported by the cited evidence; [low-conf] marks sentences with no direct anchor. Per-section confidence appears beneath each prose heading; structured per-claim classifications live in metadata.json → section_confidence.

Scope note: most sentences in the LLM-drafted sections (Introduction, Mechanistic Framework, Discussion, Conclusion) lack direct per-sentence evidence anchors. The per-section confidence gutter quantifies this; see §9 Limitations.

Figure 1: snapshot of the evidence base + claim distribution + cluster anchors used in this synthesis. Panels (a) supporting and contradicting record counts by trust tier; (b) per-section confidence for the LLM-drafted sections; (c) total claim-class distribution across those sections; (d) the cluster anchors the seed was assembled from.
Figure 1 · snapshot of the evidence base + claim distribution + cluster anchors used in this synthesis. Panels (a) supporting and contradicting record counts by trust tier; (b) per-section confidence for the LLM-drafted sections; (c) total claim-class distribution across those sections; (d) the cluster anchors the seed was assembled from.

Abstract

Evidence clusters identify a prioritization gap: candidates near known failure signals risk appearing well ranked while carrying degradation-like behavior. We propose a failure-neighborhood discriminator that assays nearest candidates as a separate subgroup, separating apparent rank from proximity to instability signals. Support is moderate and mechanism-shaped: Strategies for Improving Peptide Stability and Delivery emphasizes gut stability and barrier failure. The signal centers on proline-rich runs, including PPGP, PGPP, PPPG, and GPPG, rather than receptor pathway assignment. Contradicting records, including Gut hormone stimulation as a therapeutic approach in oral peptide delivery and cyclicpeptide, constrain degradation proximity as non-exclusive. Runtime confidence is 0.58 with evidence strength 0.45, so the §8 panel must adjudicate subgroup assay value.

1. Introduction

conf 0.08 · evidence 5 sup / 5 con · trusted-tier 4 · class mix: unr:4

We identify a prioritization gap around candidates nearest to known failure signals should be assayed as a separate subgroup so apparent rank does not hide degradation-like behavior. Our supporting evidence converges on a mechanistic surface that covers aging_pathways, antimicrobial, structural_motif. Motif analysis recovered no discriminator beyond the proposed one. We frame the present synthesis as a candidate hypothesis awaiting the experimental program in §10.

2. Methods

This synthesis was produced by Protean's autonomous thesis layer on top of the local provenance graph. The procedure for this cycle was:

1. Evidence selection. 5 supporting and 5 contradicting record(s) were drawn from the trusted-tier evidence pool. Of those, 4 carry tier TRUST_T2 or higher (peer-reviewed literature or replicated runtime measurements); the remainder are TRUST_T1 (runtime-internal observations).

2. Seed construction. A hypothesis seed (seed_115dc39e2142f203) was assembled by clustering the selected evidence on mechanistic + receptor + motif tags (cluster aging_pathways+antimicrobial+structural_motif), then proposing a discriminator hypothesis that the cited evidence could constrain or falsify.

3. Prose generation. Section bodies (Introduction, Mechanistic Framework, Discussion, Conclusion) were drafted by an LLM provider chain (openai-codex/gpt-5.5 → ollama/deepseek-r1:latest). The chain falls back deterministically when every provider fails; the deterministic skeleton is preserved verbatim in provenance.json for replay. All other sections (Methods, Related Work, Evidence Synthesis, Peptide Motif Analysis, Hypothesis, Limitations, Future Experiments, References, Provenance Appendix) are deterministic.

4. Claim classification. Every sentence in the LLM-drafted prose was passed through Protean's epistemic classifier (pipelines/autonomous_thesis/epistemics.py), which labels sentences as OBSERVED, INFERRED, WEAKLY_SUPPORTED, SPECULATIVE, UNRESOLVED, or CONTRADICTORY based on language markers and reference anchors. The per-section confidence header reports the resulting class mix.

5. Gates before publication. The full draft was scored by an internal reviewer committee + novelty engine. Both gates returned publish for this synthesis; the verdicts are persisted in provenance.json. The published markdown is additionally scrubbed by pipelines/public_thesis_export._scrub_markdown to remove any residual absolute paths, file URIs, private paths, epistemic-label markers, and HTML script tags.

Publication tier for this cycle: research_note. Tier reflects evidence strength + reviewer verdict + novelty score; it does NOT reflect peer review.

3. Related Work

The following trusted-tier references inform this synthesis:

1. Barriers and Strategies for Oral Peptide and Protein Therapeutics Delivery: Update on Clinical Advances · paperclip · source_id:PMC12030352 2. Overcoming Oral Cavity Barriers for Peptide Delivery Using Advanced Pharmaceutical Techniques and Nano-Formulation Platforms · paperclip · source_id:PMC12650023 3. On the Utility of Chemical Strategies to Improve Peptide Gut Stability · paperclip · source_id:PMC9059125 4. Strategies for Improving Peptide Stability and Delivery · paperclip 2022 · doi:10.3390/ph15101283 5. Failure Correlation metric for [redacted-seq:15aa:b9318e2a] · ranked_candidates · source_id:cycle-20260526T020837Z-02-011

4. Mechanistic Framework

conf 0.08 · evidence 5 sup / 5 con · trusted-tier 4 · class mix: unr:6

Evidence clusters converged on proline-rich runs as a degradation-risk subgroup where apparent rank requires separate oral-stability triage. PPGP couples to structural_motif because adjacent prolines restrict backbone geometry and can create protease-sensitive or protease-resistant local conformations. On the Utility of Chemical Strategies to Improve Peptide Gut Stability covers gut-stability mechanisms, including chemical modification against proteolysis. Strategies for Improving Peptide Stability and Delivery adds formulation and delivery constraints that can mask intrinsic sequence liability. The framework does not yet account for cyclic constraint rescue; Recent Trends in Cyclic Peptides as Therapeutic Agents and Biochemical Tools constrains linear-motif inference. Proteolytic stabilization of a spider venom peptide results in an orally active bioinsecticide also narrows degradation failure as a universal rule.

5. Evidence Synthesis

  • [TRUST_T2] Barriers and Strategies for Oral Peptide and Protein Therapeutics Delivery: Update on Clinical Advances — Barriers and Strategies for Oral Peptide and Protein Therapeutics Delivery: Update on Clinical Advances Peptide and protein (PP) therapeutics are highly specific and potent biomolecules that treat chronic and complex diseases. However, their oral delivery is significantly hindered by enzymatic degradation, instability, and poor permeability through the gastr (source_id:PMC12030352)
  • [TRUST_T2] Overcoming Oral Cavity Barriers for Peptide Delivery Using Advanced Pharmaceutical Techniques and Nano-Formulation Platforms — Overcoming Oral Cavity Barriers for Peptide Delivery Using Advanced Pharmaceutical Techniques and Nano-Formulation Platforms Therapeutic peptides have gained significant attention due to their high specificity, potency, and safety profiles in treating various diseases. However, their clinical application via the oral route remains challenging. Peptides are i (source_id:PMC12650023)
  • [TRUST_T2] On the Utility of Chemical Strategies to Improve Peptide Gut Stability — On the Utility of Chemical Strategies to Improve Peptide Gut Stability Inherent susceptibility of peptides to enzymatic degradation in the gastrointestinal tract is a key bottleneck in oral peptide drug development. Here, we present a systematic analysis of (i) the gut stability of disulfide-rich peptide scaffolds, orally administered peptide therapeutics, a (source_id:PMC9059125)
  • [TRUST_T2] Strategies for Improving Peptide Stability and Delivery — Peptides play an important role in many fields, including immunology, medical diagnostics, and drug discovery, due to their high specificity and positive safety profile. However, for their delivery as active pharmaceutical ingredients, delivery vectors, or diagnostic imaging molecules, they suffer from two serious shortcomings: their poor metabolic stabilit… (doi:10.3390/ph15101283)
  • [TRUST_T1] Failure Correlation metric for [redacted-seq:15aa:b9318e2a] — failure_similarity_score=0.962; notes=0.9624 similarity against 4 failure examples (source_id:cycle-20260526T020837Z-02-011)

6. Peptide Motif Analysis

Recurring 4-mer motifs in associated candidates: PPGP, PGPP, PPPG, GPPG, PPGW, PGWP, GWPP, PCPP, GPPP, CPPG.

0 candidate sequences are referenced by opaque ID — raw sequences remain in the private workspace by design (publication boundary). Operators can resolve the IDs locally via papers/candidates/.

7. Hypothesis

Statement. Candidates nearest to known failure signals should be assayed as a separate subgroup so apparent rank does not hide degradation-like behavior.

Type. failure-correlation. Engine confidence. 0.58. Aggregate uncertainty (this thesis). 0.40.

8. Discussion

conf 0.08 · evidence 5 sup / 5 con · trusted-tier 4 · class mix: unr:10

Evidence clusters indicate that, if the §8 panel supports the hypothesis, candidates nearest failure signals should move into a gated degradation-risk subgroup. Prioritization would rank efficacy-like scores only after oral-barrier exposure and gut-stability stress, consistent with Barriers and Strategies for Oral Peptide and Protein Therapeutics Delivery. Motif-family scoring would penalize proline-rich runs containing PPGP, PGPP, PPPG, and GPPG when they colocate with failure-correlation neighborhoods. Strategies for Improving Peptide Stability and Delivery supports separating stability engineering from target ranking, rather than blending both into one score. Recent Trends in Cyclic Peptides as Therapeutic Agents and Biochemical Tools constrains this shift because cyclic scaffolds can decouple motif rank from degradation-like behavior.

Contradiction weighting would narrow candidate deprioritization if §8 gut-hormone assays show activity near failure signals, constrained by Gut hormone stimulation. cyclicpeptide and Recent Trends in Cyclic Peptides constrain motif-family penalties; §8 cyclic-stability counterpanels adjudicate whether cyclization rescues proline-rich runs. Protease production by Serratia liquefaciens constrains degradation interpretation; §8 exogenous-protease challenge tests whether failure-neighbor motifs yield antimicrobial fragments instead. Proteolytic stabilization of a spider venom peptide constrains receptor-screen sequencing; §8 oral-activity rescue assays test whether stabilization should precede deprioritization. Given evidence_strength 0.45 and uncertainty_score 0.40, this remains a proposal for subgroup triage, not broad candidate exclusion.

9. Limitations

  • Synthesis class. This paper is an autonomous proposal, not a peer-reviewed result. The LLM-drafted sections (Introduction, Mechanistic Framework, Discussion, Conclusion) are constrained by the per-section confidence gates but are not yet adjudicated by human reviewers.
  • Evidence scope. Conclusions are constrained to Protean's runtime provenance graph at the time of this cycle; sources not yet ingested are by construction absent from the synthesis.
  • No wet-lab validation. Computational rankings are research prioritization, not biological proof. Acceptance of any specific claim requires the experiments outlined in §10.
  • Low evidence strength. Aggregate evidence strength is 0.45 (max 1.0). Individual sentence-level confidence is reported per section; the claim graph behind those numbers lives in provenance.json.
  • Unresolved contradictions. 5 contradicting reference(s) are acknowledged and have not been resolved within this cycle. Direct replication of those records is among the highest-value follow-ups.

10. Future Experiments

ExperimentHypothesis testedPrimary readoutFalsification criterion
Motif-resolved protease challengeCandidates carrying PPGP, PGPP, PPPG, GPPG, PPGW, PGWP retain integrity longer than motif-stripped controlsLC-MS intact-peptide tracking over 0/30/120 min exposure to a standard protease cocktailMotif-bearing and control candidates show indistinguishable degradation half-lives
Contradiction replicationThe conflict identified in the contradicting reference(s) reproduces under Protean's standard assay conditionsSame primary readout as the original record; comparison statistic depends on the conflict classOriginal contradictory result fails to reproduce; the synthesis claim survives unchallenged
Developability triageTop candidates pass standard developability filters (solubility, aggregation, hERG, hepatotoxicity proxies)Profile against the in-house developability filter panelCandidates fail developability filters faster than Protean's baseline rate (>50%)

11. Conclusion

conf 0.08 · evidence 5 sup / 5 con · trusted-tier 4 · class mix: unr:4

We rank the hypothesis on 5 trusted reference(s) at aggregate uncertainty 0.40. We recommend the §10 experimental program as the next step. Contradicting records constrain the claim surface but do not retire it. At the present runtime confidence, this remains a proposal.

12. References

Supporting (trusted tier):

1. Barriers and Strategies for Oral Peptide and Protein Therapeutics Delivery: Update on Clinical Advances · [TRUST_T2] · source_id:PMC12030352 2. Overcoming Oral Cavity Barriers for Peptide Delivery Using Advanced Pharmaceutical Techniques and Nano-Formulation Platforms · [TRUST_T2] · source_id:PMC12650023 3. On the Utility of Chemical Strategies to Improve Peptide Gut Stability · [TRUST_T2] · source_id:PMC9059125 4. Strategies for Improving Peptide Stability and Delivery · [TRUST_T2] · doi:10.3390/ph15101283 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610364/ 5. Failure Correlation metric for [redacted-seq:15aa:b9318e2a] · [TRUST_T1] · source_id:cycle-20260526T020837Z-02-011

Contradicting:

1. Gut hormone stimulation as a therapeutic approach in oral peptide delivery · [TRUST_T2] · source_id:PMC11413617 2. cyclicpeptide : a Python package for cyclic peptide drug design · [TRUST_T2] · source_id:PMC11713021 3. Protease production by Serratia liquefaciens NRC1 using fish gut waste as a sustainable approach to antimicrobial peptide generation and combating Candida auri… · [TRUST_T2] · source_id:PMC12220321 4. Proteolytic stabilization of a spider venom peptide results in an orally active bioinsecticide · [TRUST_T2] · source_id:PMC12441774 5. Recent Trends in Cyclic Peptides as Therapeutic Agents and Biochemical Tools · [TRUST_T2] · source_id:PMC6939695

13. Computational Investigation

Runtime capability investigation. Before this synthesis was drafted, Protean queried Galen's bounded capability surface to enrich the seed with structural and prior-art context. The full investigation ledger is preserved in the private snapshot (investigation.json); this section reports the public-safe rollup.

  • Wall-clock duration: 17 ms
  • Capability calls: db.uniprot:motif_search: 3, pdb: 1
  • Call statuses: ok: 1, skipped: 3

Motifs investigated against UniProt:

  • PPGP → no family-level hits
  • PGPP → no family-level hits
  • PPPG → no family-level hits

PDB cross-references (0 resolved):

  • No PDB IDs mentioned in supporting evidence.

Candidate-sequence QC distribution. No candidate sequences were resolvable for this seed.

Structural analog search. 0 Foldseek ticket(s) were submitted against AFDB50 + PDB100; results poll asynchronously and are appended in subsequent cycles.

Prior-failure motif overlap. The following seed motifs also appear in prior rejected/low-scoring candidates and warrant caution in §9 prioritization: CPPG, GWPP, PCPP, PGWP.

14. Provenance Appendix

Full provenance — evidence lineage, novelty trace, reviewer findings, per-section LLM call log, per-claim classifications — is persisted to provenance.json alongside this thesis.

  • seed_id: seed_115dc39e2142f203
  • hypothesis_id: hypothesis:failure-correlation:018924c304ce
  • publication_tier: research_note
  • cluster_id: aging_pathways+antimicrobial+structural_motif
  • thesis_layer: protean.autonomous_thesis.v1

To audit: read provenance.json in the same directory.

Citation

How to cite.

@misc{protean_thesis_thesis_79bbaa13db547838,
  title  = {Candidate validation subgroups distinguished by proximity to known failure signals},
  author = {Protean Labs — Mechanistic Thesis Layer},
  year   = {2026},
  url    = {https://www.protean.sh/papers/thesis_79bbaa13db547838},
  note   = {Mechanistic hypothesis proposal — not peer-reviewed.
            Computational rankings are research prioritization, not biological proof.}
}

Computational rankings are research prioritization, not biological proof. Wet-lab review remains authoritative.